Schedule 13G ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,806,414
Percent of class
10.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-000909
Form type
SC 13G/A
Filer
Decoy Therapeutics Inc.
CIK
CIK 1615219
Filed
Jan 05, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub